Daniel M. Hayes
About
In The Last Decade
Daniel M. Hayes
18 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 107
- Oncology 679
- Pathology and Forensic Medicine 408
- Public Health, Environmental and Occupational Health 371
- Pediatrics, Perinatology and Child Health 268
- Pulmonary and Respiratory Medicine 258
Countries citing papers authored by Daniel M. Hayes
This map shows the geographic impact of Daniel M. Hayes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel M. Hayes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel M. Hayes more than expected).
Fields of papers citing papers by Daniel M. Hayes
This network shows the impact of papers produced by Daniel M. Hayes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel M. Hayes. The network helps show where Daniel M. Hayes may publish in the future.
Co-authorship network of co-authors of Daniel M. Hayes
This figure shows the co-authorship network connecting the top 25 collaborators of Daniel M. Hayes. A scholar is included among the top collaborators of Daniel M. Hayes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel M. Hayes. Daniel M. Hayes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 5 | |
| 3 | Developing regional weight-for-age growth references to optimize age-based dosing of antimalarials | 1 |
| 4 | 8 | |
| 5 | 1 | |
| 6 | American Society of Clinical Oncology Statement: Toward Individualized Care for Patients With Advanced Cancer breakdown → | 388 |
| 7 | 3 | |
| 8 | 31 | |
| 9 | 6 | |
| 10 | 1 | |
| 11 | 134 | |
| 12 | 19 | |
| 13 | 6 | |
| 14 | 3 | |
| 15 | Phase II study of oral idarubicin in favorable histology non-Hodgkin's lymphoma. | 29 |
| 16 | 12 | |
| 17 | 283 | |
| 18 | High dose Cis-platinum diammine dichloride.Amelioration of renal toxicity by mannitol diuresis breakdown → | 512 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.